Third Pole Therapeutics Expands Board of Directors
Veteran Pharmaceutical Industry Executives William Heiden and Werner Cautreels, Ph.D., Add Critical Expertise
News provided by
Share this article
Share this article
WALTHAM, Mass., Feb. 24, 2021 /PRNewswire/ Third Pole, Inc., a privately held company developing and delivering critical life-sustaining cardio-pulmonary therapies, announced today that it has added two seasoned pharmaceutical executives to its Board of Directors, William Heiden, former CEO and Director of AMAG Pharmaceuticals, and Werner Cautreels, Ph.D., former CEO of Selecta Biosciences. Third Pole is at an exciting juncture with the Series B financing nearing completion and a strong corporate partner in place, said Bill Athenson, Third Pole s CEO. Mr. Heiden and Dr. Cautreels each brings important strategic acumen and a tremendous set of highly leverageable relevant business experiences to our board. They are joining at a perfect time to support impor